provider
Search result for "Solr search content"
Search Result for "hematology"
Clinical Trial
An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (CTMS# 18-0071)
This is an open-label, single arm, Phase 2 study evaluating the efficacy and safety of avapritinib (BLU-285) in patients with advanced systemic mastocytosis (AdvSM), including patients with aggressive SM (ASM), SM with associated hematologic neoplasm (SM-AHN), and mast cell leukemia (MCL)
provider
Krystal Robinson, PSYD Clinical Child & Adolescent Psychology, Pediatric Hematology Oncology
provider
Virginia Kaklamani, MD Breast Oncology, Hematology Oncology
provider
Supreet Kaur, M.D. Hematology Oncology
provider
Anand Karnad, M.D. Hematology/Oncology, Medical Oncology
provider
Shafqat Shah, M.D. Pediatric Hematology/Oncology, Pediatrics
provider
William Kelly, M.D. Neuro-Oncology, Hematology Oncology
provider
Melissa Frei–Jones, M.D. Pediatric Hematology
provider